Aptagen, LLC
G-NB3 (ID# 8113)
DNA
Activated Protein C
Protein
0.17 nM (reported value)
1X PBS
22°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5'-dGpdApdTpdTpdGpdTpdTpdApdCpdTpdGpdTpdCpdApdCpdGpdApdGpdGpdApdTpdTpdGpdGpdGpdGpdGpdTpdTpdGpdGpdGpdTpdGpdGpdApdTpdApdGpdGpdCpdTpdGpdGpdCpdGpdTpdCpdGpdGpdGpdGpdCpdApdGpdGpdTpdCpdApdGpdTpdApdTpdApdGpdCpdApdCpdApdTpdTpdApdGpdTpdTpdCpdApdGpdApdTpdApdCp-3'
82
25630.6
807400
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Hamedani, N. S., Müller, J., Tolle, F., Rühl, H., Pezeshkpoor, B., Liphardt, K., … Pötzsch, B. (2020). Selective Modulation of the Protease Activated Protein C Using Exosite Inhibiting Aptamers. Nucleic Acid Therapeutics. doi:10.1089/nat.2020.0844
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.